Search results
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory...
Morningstar· 4 days agoPfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily pretreated relapsed ...
What Are Night Driving Glasses? Do They Even Work?
CNET· 5 hours agoDriving at night and balancing the deep dark with bright, oncoming headlights can strain the eyes significantly and cause temporary vision troubles. One...
Congenital Pigment Disorders May Need Special Management
Medscape· 6 days agoCongenital disorders of pigmentation are numerous and can have mild to severe effects, and some have...
Former Aggie RB Darren Lewis turns life around and is now fighting for it
The Bryan-College Station Eagle· 6 days agoThe 5-foot-10, 219-pound Lewis was virtually unstoppable from the first time he walked onto a...
Emotional Support Chapstick No Longer Working? Here's What It Could Mean
Women's Health via AOL· 4 days agoWeather, diet, and health conditions can cause dry, cracked lips. Here's what causes peeling,...
Cantor Fitzgerald L. P. Has $362,000 Stock Holdings in Adlai Nortye Ltd. (NASDAQ:ANL)
ETF DAILY NEWS· 6 days agoCantor Fitzgerald L. P. boosted its position in Adlai Nortye Ltd. (NASDAQ:ANL – Free Report) by 128.2% during the fourth quarter, according to the company in its most recent 13F filing with ...
Merus N.V. VP controller Harry Shuman sells shares worth over $475,000 By Investing.com
Investing.com· 6 days agoIn a recent transaction, Harry Shuman, the VP Controller and Principal Accounting Officer (PAO) of...
Birchview Capital LP Invests $216,000 in Castle Biosciences, Inc. (NASDAQ:CSTL)
ETF DAILY NEWS· 5 days agoBirchview Capital LP acquired a new position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 10,000 shares ...